Enhanced detection of human IL-5 in biological fluids utilizing murine monoclonal antibodies which delineate distinct neutralizing epitopes

Cytokine

Volumn 6, Issue 6, 1994, Pages 647-656

  Dickason, Richard R ^a   Huston, Marilyn M ^a   Huston, David P ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

conformational epitope; human interleukin 5; monoclonal antibody; sandwich ELISA; Western

Indexed keywords

EPITOPE; INTERLEUKIN 5; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; RECOMBINANT INTERLEUKIN 5;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN BINDING; ANTIGEN RECOGNITION; ARTICLE; BACULOVIRUS; BIOASSAY; BLOOD LEVEL; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HYBRIDOMA; IMMUNOBLOTTING; LUNG LAVAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DETERMINATION;

ANIMAL; ANTIBODIES, MONOCLONAL; BASE SEQUENCE; BIOLOGICAL ASSAY; BLOTTING, WESTERN; CELL DIVISION; CELL LINE; CLONING, MOLECULAR; COMPARATIVE STUDY; DNA PRIMERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; HUMAN; INTERLEUKIN-5; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; RECOMBINANT PROTEINS; SENSITIVITY AND SPECIFICITY; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

ANIMALIA; MURINAE; UNIDENTIFIED BACULOVIRUS;

EID: 0028104198     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/1043-4666(94)90053-1     Document Type: Article

References (60)

1. T cell replacing factor (TRF)/interleukin-5 (IL-5): molecular and functional properties
2. T cells from eosinophilic patients produce interleukin-5 with interleukin-2 stimulation
3. Aberrent interleukin (IL)-4 and IL-5 production in vitro by CD4+ helper T cells from atopic subjects
4. Interleukin-5 is the predominant eosinophilopoietin produced by cloned T lymphocytes in hypereosinophilic syndrome
5. Mutated interleukin-5 monomers are biologically inactive
6. 1 cells and its implication in biological activity
7. Structure of recombinant human interleukin 5 produced by Chinese hamster ovary cells
8. Structural comparison of murine T-cell (B151K12)-derived T-cell-replacing factor (IL-5) with rIL-5: dimer formation is essential for the expression of biological activity
9. Role of carbohydrate moiety of IL-5: effect of tunicamycin on the glycosylation of IL-5 and biologic activity of deglycosylated IL-5
10. Role of sugar chains in the in-vitro activity of recombinant human interleukin-5
11. Preparation and characterization of human interleukin-5 expressed in recombinant Escherichia coli
12. Structure-function analysis of interleukin-5 utilizing mouse/human chimeric molecules
13. Characterization of interleukin 5 receptors on eosinophilic sublines from human promyelocytic leukemia (HL-60) cells
14. A novel dimer configuration revealed by the crystal structure at 2.4 angstrom resolution of human interleukin-5
15. Interleukin 5 (IL-5) and Its Receptor
16. Cloning of cDNA for human T-cell replacing factor (interieukin-5) and comparison with the murine homologue
17. Isolation and characterization of lymphokine cDNA clones encoding mouse and human IgA-enhancing factor and eosinophil colony-stimulating factor activities: relationship to interleukin 5.
18. Recombinant human interleukin 5 is an eosinophil differentiation factor but has no activity in standard human B cell growth factor assays
19. Human interleukin-5 induces staphylococcal A cowan 1 strain-activated human B cells to secrete IgM
20. Effect of recombinant interleukin 5 on the generation of cytotoxic T cells (CTL)
21. Interleukin 5, a T-cell-derived B-cell differentiation factor also induces cytotoxic T lymphocytes.
22. Human IL-5 augments IL-2-dependent T cell proliferation
23. Interleukin 5 enhances interleukin 2-mediated lymphokine-activated killer activity
24. T cells from eosinophilic patients produce interleukin-5 with the interleukin-2 stimulation
25. Selective differentiation and proliferation of hematopoietic cells induced by recombinant human interleukins.
26. Analysis of the survival of mature human eosinophils: interleukin-5 prevents apoptosis in mature human eosinophils
27. Glucocorticoids inhibit cytokine-mediated eosinophil survival
28. Apoptosis in human eosinophils
29. Activation by human recombinant IL-5 of guinea pig eosinophils
30. Recombinant human interleukin-5 is a selective eosinophil chemoattractant
31. Regulatory effect of cytokines on eosinophil degranulation
32. Interleukin-5 is a human basophilopoietin: induction of histamine content and basophilic differentiation of HL-60 and of peripheral blood basophil-eosinophil progenitors
33. Enhancement of human basophil histamine release by interleukin 5
34. Interleukin 5 modifies histamine release and leukotriene generation by human basophils in response to diverse agonists
35. Predominant TH2-like bronchoalveolar T-lymphocytes population in atopic asthma
36. Expression of mRNA for Interleukin-5 in mucosal bronchial biopsies from asthma
37. CD4 T-lymphocyte activation in asthma is accompanied by increased serum concentration of interleukin-5
38. Cytokine messenger RNA expression for IL-3, IL-4, IL-5 granulocyte/macrophage-colony-stimulating factor in the nasal mucosa after local allergen provocation: relationship to tissue eosinophilia
39. Interleukin-5 selectively enhances the chemotactic response of eosinophils obtained from normal but not eosinophilic subjects
40. IL-5 is the predominant eosinophil-active cytokine in the antigen-induced pulmonary late-phase reaction
41. The characterization of four monoclonal antibodies specific for mouse IL-5 and development of mouse and human IL-5 enzyme-linked immunosorbent
42. Production, characterization and use of monoclonal antibodies to human interleukin-5 in an enzyme-linked immunosorbent assay
43. A sandwich enzyme-linked immunosorbent assay for human interleukin-5
44. Interleukin-5 and the post-treatment eosinophilia in patients with onchocerciasis
45. Recombinant soluble human interleukin-5 (hIL-5) receptor molecules
46. Receptor and antibody epitopes in growth identified by homologous-scanning mutagenesis
47. Identification of functionally distinct domains of human granulocytes-macrophage colony-stimulating factor using monoclonal antibodies
48. Structure-function relationships of interleukin-3
49. Immunochemical mapping of domains in human interleukin 4 recognized by neutralizing monoclonal antibodies
50. Antibody to interleukin-5 inhibits helminth-induced eosinophilia in mice
51. In vivo administration of antibody to interleukin-5 inhibits increased generation of eosinophils and their progenitors in bone marrow and parasitized mice
52. Effect of Anti-IL-5 and IL-5 on Airway Hyperreactivity and Eosinophils in Guinea Pigs
53. Isolation and characterization of lymphokine cDNA clones encoding mouse and human IgA-enhancing factor and eosinophil colony stimulating factor activities: relationship to interleukin-5
54. Rapid methods for purification of human recombinant interleukin-5 (IL-5) using the anti-murine IL-5 antibody-coupled immunoaffinity column
55. Measurement of mouse and human interleukin-5
56. Utilization of the biotin/avidin system to amplify the sensitivity of the enzyme-linked immunosorbent assay (ELISA)
57. Induction of IL-5 receptor on normal B cells by cross-linking surface Ig with anti-Ig-dextran
58. A solid-phase immunoenzymatic technique for the enumeration of specific antibody-secreting cells